Search filters

List of works by Mattias Carlsten

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

scientific article published on 21 March 2014

A short-term dietary supplementation with high doses of vitamin E increases NK cell cytolytic activity in advanced colorectal cancer patients.

scientific article published on 2 December 2006

Bortezomib sensitizes multiple myeloma to NK cells via ER-stress-induced suppression of HLA-E and upregulation of DR5

scientific article published on 02 November 2018

Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma

scientific article published on 15 June 2016

Coordinated expression of DNAM-1 and LFA-1 in educated NK cells

scientific article published on 30 March 2015

DNAX Accessory Molecule-1 Mediated Recognition of Freshly Isolated Ovarian Carcinoma by Resting Natural Killer Cells

scientific article published on 01 February 2007

Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling

scientific article published on 11 April 2013

Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7 Augments Rituximab-Induced ADCC against Lymphoma and Targets NK Cell Migration toward the Lymph Node-Associated Chemokine CCL19.

scientific article published on 22 March 2016

Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype

scientific article published in November 2008

Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.

scientific article published on June 2006

Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications

scientific article published on 10 June 2015

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

scientific article

Natural killer cell-mediated lysis of freshly isolated human tumor cells.

scientific article published on February 2009

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells

scientific article

Prominent expression of the selenoprotein thioredoxin reductase in the medullary rays of the rat kidney and thioredoxin reductase mRNA variants differing at the 5' untranslated region

scientific article published on May 2000

Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome.

scientific article published on 8 July 2010

Regulation of interleukin-4 signaling by extracellular reduction of intramolecular disulfides

scientific article published on 28 October 2009

Selenite induces posttranscriptional blockade of HLA-E expression and sensitizes tumor cells to CD94/NKG2A-positive NK cells.

scientific article

The core promoter of human thioredoxin reductase 1: cloning, transcriptional activity, and Oct-1, Sp1, and Sp3 binding reveal a housekeeping-type promoter for the AU-rich element-regulated gene.

scientific article published on 24 May 2001

Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens.

scientific article published on 22 May 2015

Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers.

scientific article

mRNA Transfection to Improve NK Cell Homing to Tumors

scientific article published in January 2016